Neuroinflammation, driven by microglial activation and excessive pro-inflammatory cytokine release, is a key contributor to Alzheimer’s disease (AD) pathology, with the NF-κB signaling pathway playing a central role in sustaining chronic inflammation. This evidence concerns the gene NFKB1 and Alzheimer disease.